Summary
- The United Arab Emirates has become the first country in the world to approve a new breast cancer treatment called Etkamah, marking a significant step forward in cancer care.
- Health authorities in the UAE believe the treatment could offer new hope to patients with certain types of breast cancer.
- Etkamah works by targeting and blocking estrogen receptors found in breast cancer cells.
The United Arab Emirates has become the first country in the world to approve a new breast cancer treatment called Etkamah, marking a significant step forward in cancer care.
The medication, developed by AstraZeneca, received approval after delivering encouraging results in Phase III clinical trials. Health authorities in the UAE believe the treatment could offer new hope to patients with certain types of breast cancer.
Etkamah works by targeting and blocking estrogen receptors found in breast cancer cells. In many cases, these receptors act as a source of fuel that helps tumors grow and spread throughout the body. By preventing estrogen from activating these receptors, the drug can slow disease progression and improve treatment outcomes.
Medical experts consider the approval an important milestone in the fight against breast cancer, one of the most common cancers affecting women worldwide. The decision also highlights the UAE’s growing role in supporting medical innovation and accelerating access to advanced therapies for patients.
We welcome your contributions! Submit your blogs, opinion pieces, press releases, news story pitches, and news features to [email protected] and [email protected]
